Why is Dr Agarwal's Eye falling/rising?

As of 19-Sep, Dr Agarwals Eye Hospital Ltd is experiencing a slight increase in its stock price, currently at 4,720.00, reflecting a change of 13.5, or 0.29% upward. The stock has shown positive momentum, outperforming its sector by 0.48% today and achieving consecutive gains over the last two days, with a total return of 1.48% during this period. Additionally, the stock has performed well over the past week and month, with returns of 1.51% and 6.62%, respectively. Despite a significant decline of 22.96% year-to-date, the company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 61.38%. Positive financial results, including a 23.61% growth in PAT and record net sales, contribute to the stock's favorable outlook, although a notable drop in investor participation is observed with a 78.22% decrease in delivery volume. Broader Market Context: In comparison to the benchmark, Dr Agarwals Eye Hospital Ltd has outperformed the Sensex over the past week and month, which recorded returns of 0.88% and 1.20%, respectively. This indicates that the stock is gaining traction relative to the broader market, despite its year-to-date performance lagging behind the Sensex's 5.74% increase. The stock's consistent returns over the last three years, along with a fair valuation compared to peers, suggest that it remains an attractive investment option, even as it faces challenges in the short term.